Predictive Factors for Diagnosis and Treatment Delay in Iranian Women with Breast Cancer

Nastaran Mirfarhadi, Atefeh Ghanbari, Malahat Khalili, Abbas RahimiNursing 2016 · DOI

TL;DR

This study investigates factors contributing to delays in breast cancer diagnosis and treatment among Iranian women, revealing that lack of insurance, lower education, and advanced disease stages are significant predictors of patient delay. The findings underscore the critical need for improved public education, accessible screening programs, and robust healthcare infrastructure to mitigate these delays and improve patient outcomes.

What Problem Does This Paper Address?

Breast cancer is a growing public health concern, particularly in Iran, where cases are often detected at later stages compared to Western countries. This delay in diagnosis and treatment is a significant challenge, leading to adverse consequences and reduced survival rates. The paper aims to identify the specific factors that contribute to these delays in Iranian women, differentiating between "patient delay" (time from symptom detection to first physician visit) and "system delay" (time from first physician visit to initiation of treatment). Understanding these predictors is crucial for developing targeted interventions to improve early detection and timely access to care.

Methods

This cross-sectional study employed a quantitative approach, collecting data from 232 breast cancer patients at Razi Hospital in Guilan Province, Iran. The researchers utilized a six-section questionnaire administered through face-to-face interviews and supplemented with information from medical records. Data analysis involved descriptive statistics, univariate and multivariate logistic regression, and chi-square tests to identify significant predictors of patient delay. The questionnaire's validity was assessed by ten experts, and its reliability was confirmed through a test-retest method.

Datasets

The study utilized data collected from 232 breast cancer patients diagnosed at Razi Hospital in Rasht, Iran, between September and November 2013. This dataset is specific to the study's context and was not a pre-existing benchmark.

Key Insights and Ideas

  • Insurance as a Barrier: Lack of both primary and complementary insurance emerged as a significant predictor of patient delay. This highlights how financial barriers can directly impede timely healthcare seeking.
  • Disease Stage Matters: More advanced stages of breast cancer (Stage II and III) were strongly associated with patient delay, suggesting that women with more severe symptoms might still delay seeking care, or that the delay itself contributes to disease progression.
  • Knowledge Gaps Persist: A significant portion of patients lacked knowledge about breast cancer symptoms, common cancers in women, and the importance of self-examination. This points to a critical need for enhanced public health education campaigns.
  • Systemic Issues: While patient factors are significant, the study also touches upon system delays, noting that the limited availability of specialized facilities (like a single chemotherapy center in the region) can contribute to delays in treatment initiation.

Key Results

  • Prevalence of Delay: Approximately one-third of patients experienced a patient delay of more than three months. System delays were also noted, with 16.8% of cases experiencing a delay between diagnosis and biopsy, and 13% between biopsy and treatment.
  • Predictors of Patient Delay:
    • Stage of Disease: Stage II (OR = 7.19) and Stage III (OR = 1.95) were significant predictors of delay.
  • Insurance: Lack of complementary insurance (OR = 2.26) and primary insurance (OR = 3.52) were important risk factors.
  • Knowledge and Attitude: Significant differences were found in knowledge and attitudes regarding breast cancer symptoms, diagnosis methods, and self-examination between patients with and without treatment delay.
  • Tumor Characteristics: 60% of patients had tumors larger than 5 cm, and 46% had lymph node involvement at diagnosis, indicating advanced disease at presentation.

Limitations and Future Work

The authors acknowledge that gathering samples solely from a governmental center may limit the generalizability of the findings, as it doesn't capture experiences from the private healthcare system. Additionally, the assessment of system delay was based on only three variables, which is a limitation.

Future research is recommended to include multicenter studies with larger sample sizes, incorporate data from the private healthcare sector, and develop more comprehensive instruments for assessing knowledge, attitudes, and the duration of refused treatment initiation. The study also suggests that the government has a crucial role in establishing organized screening programs, providing public education on breast cancer signs and screening methods, and ensuring universal insurance coverage for diagnostic and treatment procedures.

Summary updated

BibTeX
@inproceedings{mirfarhadi2016predictive,
  author = {Nastaran Mirfarhadi and Atefeh Ghanbari and Malahat Khalili and Abbas Rahimi},
  title = {{Predictive Factors for Diagnosis and Treatment Delay in Iranian Women with Breast Cancer}},
  booktitle = {Nursing},
  year = {2016},
  doi = {10.17795/nmsjournal27452},
}
Figure